Cellectis SA · Paris France
| 8 Rue De La Croix Jarry | Phone: +33-1-81-69-16-00 |
| Paris | |
| 75013 | |
| France | 
Map This Company |
Cellectis SA Rankings
Company Description
Cellectis has found a cure for bad genes. The company develops technologies involving the research and development of rational genome engineering (making changes in the genetics of a cell or organism). The company's research is primarily based on the Meganucleasus, a natural classification of DNA that isolates unique breaks at key locations within living cells. Its patented Meganuclease Recombination Systems technology helps to initiate the rational genome engineering process, which in turn can help treat diseases and augment genetic codes. In 2010 Cellectis established Cellectis Bioresearch Inc., a US subisidiary responsible for promotion of Cellectis' products in the states.
Cellectis SA Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 129 |
Executives
9 executives listed for Cellectis SA's Paris, France location.
| Chairman | Christian Policard | |
|---|---|---|
| CEO and Director | André Choulika | |
| EVP Corporate Development and Director | David Sourdive |